SAPPORO MEDICAL UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1950-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://web.sapmed.ac.jp/e
Clinical Trials
98
Active:0
Completed:56
Trial Phases
4 Phases
Phase 1:7
Phase 2:2
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (96 trials with phase data)• Click on a phase to view related trials
Not Applicable
86 (89.6%)Phase 1
7 (7.3%)Phase 2
2 (2.1%)Phase 4
1 (1.0%)EXTEND ARDS-J Esophageal Pressure Study
Recruiting
- Conditions
- ARDS (Acute Respiratory Distress Syndrome)
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Sapporo Medical University
- Target Recruit Count
- 100
- Registration Number
- NCT06734988
- Locations
- 🇯🇵
Sapporo Medical University, Sapporo, Hokkaido, Japan
Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2014-11-02
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- Sapporo Medical University
- Target Recruit Count
- 190
- Registration Number
- NCT02280837
- Locations
- 🇯🇵
Sapporo Medical University, School of Medicine, Sapporo, Hokkaido, Japan
Optimization of Desflurane in Elderly Patients
Phase 1
Completed
- Conditions
- Postoperative Cognitive Dysfunction
- Interventions
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2014-11-27
- Lead Sponsor
- Sapporo Medical University
- Target Recruit Count
- 20
- Registration Number
- NCT01700907
- Locations
- 🇯🇵
Sapporo Medical University, School of Medicine, Sappro, Hokkaido, Japan
News
No news found